Principal Financial Group’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-37,350
| Closed | -$1.73M | – | 2540 |
|
|
2022
Q1 | $1.73M | Buy |
37,350
+58
| +0.2% | +$2.69K | ﹤0.01% | 1884 |
|
|
2021
Q4 | $2.64M | Buy |
37,292
+7,142
| +24% | +$506K | ﹤0.01% | 1818 |
|
|
2021
Q3 | $3.51M | Buy |
30,150
+469
| +2% | +$54.6K | ﹤0.01% | 1780 |
|
|
2021
Q2 | $4.65M | Buy |
29,681
+11,481
| +63% | +$1.8M | ﹤0.01% | 1735 |
|
|
2021
Q1 | $3.45M | Buy |
18,200
+2,337
| +15% | +$443K | ﹤0.01% | 1755 |
|
|
2020
Q4 | $1.99M | Buy |
15,863
+913
| +6% | +$115K | ﹤0.01% | 1801 |
|
|
2020
Q3 | $1.63M | Buy |
14,950
+475
| +3% | +$51.7K | ﹤0.01% | 1775 |
|
|
2020
Q2 | $1.74M | Buy |
14,475
+37
| +0.3% | +$4.45K | ﹤0.01% | 1722 |
|
|
2020
Q1 | $1.45M | Hold |
14,438
| – | – | ﹤0.01% | 1670 |
|
|
2019
Q4 | $3.5M | Sell |
14,438
-16
| -0.1% | -$3.88K | ﹤0.01% | 1621 |
|
|
2019
Q3 | $2.37M | Sell |
14,454
-134
| -0.9% | -$22K | ﹤0.01% | 1693 |
|
|
2019
Q2 | $3.44M | Sell |
14,588
-143
| -1% | -$33.8K | ﹤0.01% | 1629 |
|
|
2019
Q1 | $3.88M | Sell |
14,731
-2,144
| -13% | -$565K | ﹤0.01% | 1620 |
|
|
2018
Q4 | $1.54M | Sell |
16,875
-8,816
| -34% | -$804K | ﹤0.01% | 1749 |
|
|
2018
Q3 | $4.94M | Buy |
25,691
+76
| +0.3% | +$14.6K | ﹤0.01% | 1610 |
|
|
2018
Q2 | $5.53M | Buy |
+25,615
| New | +$5.53M | 0.01% | 1564 |
|